The relevance of complement in pemphigoid diseases: A critical appraisal DOI Creative Commons
Cristian Papara, Christian M. Karsten, Hideyuki Ujiie

и другие.

Frontiers in Immunology, Год журнала: 2022, Номер 13

Опубликована: Авг. 16, 2022

Pemphigoid diseases are autoimmune chronic inflammatory skin diseases, which characterized by blistering of the and/or mucous membranes, and circulating tissue-bound autoantibodies. The well-established pathomechanisms comprise autoantibodies targeting various structural proteins located at dermal-epidermal junction, leading to complement factor binding activation. Several effector cells thus attracted activated, in turn inflict characteristic tissue damage subepidermal blistering. Moreover, detection linear deposits is a diagnostic hallmark all pemphigoid diseases. However, recent studies showed that might also occur independently complement. This review reassesses importance based on current research contrasting contextualizing data from vitro , murine human studies.

Язык: Английский

Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy DOI Creative Commons
Dario Didona,

Morna F. Schmidt,

Roberto Maglie

и другие.

JDDG Journal der Deutschen Dermatologischen Gesellschaft, Год журнала: 2023, Номер 21(10), С. 1188 - 1209

Опубликована: Авг. 16, 2023

Pemphigus and pemphigoid are two potentially life-threatening groups of autoimmune diseases, characterized by autoantibodies targeting structural components desmosomes or hemidesmosomes, respectively. Affected patients typically show itchy/painful plaques blistering skin lesions and/or impairing mucosal erosions, which may strongly impact their quality life. Since the milestone work Walter Lever in 1953, who differentiated these diseases histopathological analysis level antibody-mediated cleavage, enormous progresses occurred. Achievements made laboratory diagnostics now allow to identify antigen specific proteins that targeted pathogenic autoantibodies. These were accompanied an increased understanding pathogenesis thanks establishment animal models reproducing disease on studies blood affected individuals, have been leading novel disease-specific treatments. Yet, given phenotypical overlap with more common dermatological correct diagnosis appropriate treatment often delayed, some cases irreversible sequelae, including organ dysfunction (i.e., loss vision mucous membrane pemphigoid). Here, we provide a concise overview clinical appearance, therapeutic management pemphigus diseases.

Язык: Английский

Процитировано

15

Nanotechnology-Based Topical Delivery of Natural Products for the Management of Atopic Dermatitis DOI Creative Commons
Mário Pedro Marques, Carla Varela, Laura Mendonça

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(6), С. 1724 - 1724

Опубликована: Июнь 14, 2023

Atopic dermatitis (AD) is a chronic eczematous inflammatory disease that may arise from environmental, genetic, and immunological factors. Despite the efficacy of current treatment options such as corticosteroids, approaches are mainly focused on symptom relief present certain undesirable side effects. In recent years, isolated natural compounds, oils, mixtures, and/or extracts have gained scientific attention because their high efficiency moderate to low toxicity. promising therapeutic effects, applicability healthcare solutions somewhat limited by instability, poor solubility, bioavailability. Therefore, novel nanoformulation-based systems been designed overcome these limitations, thus enhancing potential, promoting capacity drugs properly exert action in AD-like skin lesions. To best our knowledge, this first literature review has summarizing loaded with ingredients, specifically for management AD. We suggest future studies should focus robust clinical trials confirm safety effectiveness natural-based nanosystems, paving way more reliable AD treatments.

Язык: Английский

Процитировано

14

Revolutionizing teledermatology: Exploring the integration of artificial intelligence, including Generative Pre-trained Transformer chatbots for artificial intelligence-driven anamnesis, diagnosis, and treatment plans DOI
Jonathan S. Shapiro,

Anna Lyakhovitsky

Clinics in Dermatology, Год журнала: 2024, Номер 42(5), С. 492 - 497

Опубликована: Июнь 27, 2024

Язык: Английский

Процитировано

5

Deciphering the Links: Fragmented Polystyrene as a Driver of Skin Inflammation DOI

Gyeong Bae Song,

J.H. Nam,

Sangmin Ji

и другие.

Journal of Hazardous Materials, Год журнала: 2024, Номер 480, С. 135815 - 135815

Опубликована: Сен. 11, 2024

Язык: Английский

Процитировано

5

The relevance of complement in pemphigoid diseases: A critical appraisal DOI Creative Commons
Cristian Papara, Christian M. Karsten, Hideyuki Ujiie

и другие.

Frontiers in Immunology, Год журнала: 2022, Номер 13

Опубликована: Авг. 16, 2022

Pemphigoid diseases are autoimmune chronic inflammatory skin diseases, which characterized by blistering of the and/or mucous membranes, and circulating tissue-bound autoantibodies. The well-established pathomechanisms comprise autoantibodies targeting various structural proteins located at dermal-epidermal junction, leading to complement factor binding activation. Several effector cells thus attracted activated, in turn inflict characteristic tissue damage subepidermal blistering. Moreover, detection linear deposits is a diagnostic hallmark all pemphigoid diseases. However, recent studies showed that might also occur independently complement. This review reassesses importance based on current research contrasting contextualizing data from vitro , murine human studies.

Язык: Английский

Процитировано

19